Investor Presentaiton
Peptide-based drugs market with structural growth momentum
Broad therapeutic areas with significant product pipeline
Estimated peptide therapeutics end market ($ Bn)(1)
7%
CAGR
42
222
39
36
34
32
21F
22F
23F
24F
2020
Based on a study conducted for PolyPeptide
Notes:
1.
2.
As of Dec-2020
GLOBAL SUPPORT FOR A QUALITY SOLUTION
Therapeutic areas for peptide-based drugs (1)
Other
30%
Metabolic
24%
76 Drugs Approved (2)
~$ 32 Bn
44
Neurological
5%
Cardiovascular
8%
Oncology
23%
500 Drugs In Development(2)
Gastrointestinal
9%
25F
4
Beneficial characteristics of peptides driving strong product pipeline
and investments into R&D
Expanding applications for peptide drugs
ā Increasing incidence of cancer
Rising prevalence of metabolic disorders
PolyPeptide
GROUPView entire presentation